Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late

Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late Gilead Sciences and Bristol-Myers Squibb urged A ca federal judge Thursday to nix direct purchasers’ claims alleging the pharmaceutical companies involved with anti-competitive conduct to block generic competition and keep HIV medicine rates artificially high, arguing the suits must certanly be provided for arbitration or …

Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late Read More »